- Previous Close
15,720.00 - Open
15,530.00 - Bid 15,330.00 x --
- Ask 15,340.00 x --
- Day's Range
15,120.00 - 15,820.00 - 52 Week Range
12,010.00 - 26,150.00 - Volume
42,678 - Avg. Volume
185,288 - Market Cap (intraday)
367.768B - Beta (5Y Monthly) -0.20
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.
genomictree.comRecent News: 228760.KQ
View MorePerformance Overview: 228760.KQ
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 228760.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 228760.KQ
View MoreValuation Measures
Market Cap
377.12B
Enterprise Value
283.12B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
158.88
Price/Book (mrq)
3.04
Enterprise Value/Revenue
119.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-7.26%
Return on Equity (ttm)
-8.33%
Revenue (ttm)
2.36B
Net Income Avi to Common (ttm)
-10.24B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
96.08B
Total Debt/Equity (mrq)
1.67%
Levered Free Cash Flow (ttm)
-10.08B